These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38193190)

  • 1. Computational investigation of copper-mediated conformational changes in α-synuclein dimer.
    Savva L; Platts JA
    Phys Chem Chem Phys; 2024 Jan; 26(4):2926-2935. PubMed ID: 38193190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cu
    Ramis R; Ortega-Castro J; Vilanova B; Adrover M; Frau J
    Int J Biol Macromol; 2021 Feb; 169():251-263. PubMed ID: 33345970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease.
    Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K
    Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.
    Uversky VN; Li J; Fink AL
    J Biol Chem; 2001 Nov; 276(47):44284-96. PubMed ID: 11553618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study.
    Bharathi ; Indi SS; Rao KS
    Neurosci Lett; 2007 Sep; 424(2):78-82. PubMed ID: 17714865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinorganic Chemistry of Parkinson's Disease: Affinity and Structural Features of Cu(I) Binding to the Full-Length β-Synuclein Protein.
    Miotto MC; Pavese MD; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO
    Inorg Chem; 2017 Sep; 56(17):10387-10395. PubMed ID: 28820253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
    Teng Y; Zhao J; Ding L; Ding Y; Zhou P
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Cu(II) binding affects structure and dynamics of α-synuclein revealed by molecular dynamics simulations.
    Savva L; Platts JA
    J Inorg Biochem; 2023 Feb; 239():112068. PubMed ID: 36403437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N Terminus of α-Synuclein Forms Cu(II)-Bridged Oligomers.
    Drew SC
    Chemistry; 2015 May; 21(19):7111-8. PubMed ID: 25757154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.
    Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH
    ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper ion incorporation in α-synuclein amyloids.
    Walke G; Kumar R; Wittung-Stafshede P
    Protein Sci; 2024 Apr; 33(4):e4956. PubMed ID: 38511511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of copper(II)-induced misfolding of Parkinson's disease protein.
    Rose F; Hodak M; Bernholc J
    Sci Rep; 2011; 1():11. PubMed ID: 22355530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific copper-catalyzed oxidation of α-synuclein: tightening the link between metal binding and protein oxidative damage in Parkinson's disease.
    Miotto MC; Rodriguez EE; Valiente-Gabioud AA; Torres-Monserrat V; Binolfi A; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO
    Inorg Chem; 2014 May; 53(9):4350-8. PubMed ID: 24725094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Nucleation of Polymorphic α-Synuclein Dimers Depends on Copper Concentrations and Definite Copper-Binding Site.
    Blacher C; Abramov-Harpaz K; Miller Y
    Biomolecules; 2024 May; 14(6):. PubMed ID: 38927031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peculiarities of copper binding to alpha-synuclein.
    Ahmad A; Burns CS; Fink AL; Uversky VN
    J Biomol Struct Dyn; 2012; 29(4):825-42. PubMed ID: 22208282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cu
    Wang H; Mörman C; Sternke-Hoffmann R; Huang CY; Prota A; Ma P; Luo J
    J Inorg Biochem; 2022 Nov; 236():111945. PubMed ID: 35952593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Cu(II) Binding on Structures and Dynamics of Aβ
    Huy PD; Vuong QV; La Penna G; Faller P; Li MS
    ACS Chem Neurosci; 2016 Oct; 7(10):1348-1363. PubMed ID: 27454036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation Effects of Fe
    Li Y; Yu Y; Ma G
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Particle Resolution of Copper-Associated Annular α-Synuclein Oligomers Reveals Potential Therapeutic Targets of Neurodegeneration.
    Synhaivska O; Bhattacharya S; Campioni S; Thompson D; Nirmalraj PN
    ACS Chem Neurosci; 2022 May; 13(9):1410-1421. PubMed ID: 35414168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild-Type
    Guzzo A; Delarue P; Rojas A; Nicolaï A; Maisuradze GG; Senet P
    Front Mol Biosci; 2022; 9():910104. PubMed ID: 35836937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.